Accès ouvert déclaré 2021 dataset

Additional file 1 of Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

Anna Morra, Maria Escala-Garcia, Jonathan Beesley, Renske Keeman, Sander Canisius, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton‐Culver, Volker Arndt, Paul L. Auer, Annelie Augustinsson, Laura E. Beane Freeman, Heiko Becher, Matthias W. Beckmann, Sabine Behrens, Stig E. Bojesen, Manjeet K. Bolla, Hermann Brenner, Thomas Brüning, Saundra S. Buys, Bette J. Caan, Daniele Campa, Federico Canzian, Jose E. Castelao, Jenny Chang‐Claude, Stephen J. Chanock, Ting‐Yuan David Cheng, Christine L. Clarke, Sarah V. Colonna, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Mary B. Daly, Joe Dennis, Thilo Dörk, Laure Dossus, Alison M. Dunning, Miriam Dwek, Arif B. Ekici, A. Heather Eliassen, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Henrik Flyger, Lin Fritschi, Manuela Gago-Domínguez, José Á. García-Sáenz, Graham G. Giles, Mervi Grip, Pascal Guénel, Melanie Gündert, Eric Hahnen, Christopher A. Haiman, Niclas Håkansson, Per Hall, Ute Hamann, Steven N. Hart, Jaana M. Hartikainen, Arndt Hartmann, Wei He, Maartje J. Hooning, Reiner Hoppe, John L. Hopper, Anthony Howell, David J. Hunter, Agnes Jager, Anna Jakubowska, Wolfgang Janni, Esther M. John, Audrey Jung, Rudolf Kaaks, Machteld Keupers, Cari M. Kitahara, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Allison W. Kurian, James V. Lacey, Diether Lambrechts, Loı̈c Le Marchand, Annika Lindblom, Martha S. Linet, Robert Luben, Jan Lubiński, Michael Lush, Graham J. Mann, Mehdi Manoochehri, Sara Margolin, John W.M. Martens, Marı́a Elena Martı́nez, Dimitrios Mavroudis, Kyriaki Michailidou, Roger L. Milne, Anna Marie Mulligan, Taru Muranen, Heli Nevanlinna, William G. Newman, Sune F. Nielsen, Børge G. Nordestgaard, Andrew F. Olshan, Håkan Olsson, Nick Orr, Tjoung‐Won Park‐Simon, Alpa V. Patel, Bernard Peissel, Paolo Peterlongo, Dijana Plaseska‐Karanfilska, Karolina Prajzendanc, Ross L. Prentice, Nadège Presneau, Brigitte Rack, Gad Rennert, Hedy S. Rennert, Valerie Rhenius, Atocha Romero, Rebecca Roylance, Matthias Ruebner, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Andreas Schneeweiß, Christopher G. Scott, Mitul Shah, Snezhana Smichkoska, Melissa C. Southey, Jennifer Stone, Harald Surowy, Anthony J. Swerdlow, Rulla M. Tamimi, William Tapper, Lauren R. Teras, Mary Beth Terry, Rob A.�E.�M. Tollenaar, Ian Tomlinson, Melissa A. Troester, Thérèse Truong, Celine M. Vachon, Qin Wang, Amber N. Hurson, Robert Winqvist, Alicja Wolk, Argyrios Ziogas, Hiltrud Brauch, Montserrat García‐Closas, Paul D.P. Pharoah, Douglas F. Easton, Georgia Chenevix‐Trench, Marjanka K. Schmidt

0Citations signalées, ce qui n’est pas une note de qualité

89Institutions déclarées

20Pays d’affiliation déclarés

Rattachement africain : nl, au, ca, us, de, Afrique du Sud, se, gb, it, fr, dk, es, fi, pl, be, no, gr, cy, il, mk. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Additional file 1: Supplementary Table S1, Supplementary Table S2, Supplementary Table S3, and Supplementary Table S4. Supplementary Table S1. Shows an overview of the Breast Cancer Association Consortium studies included in the analyses. Supplementary Table S2. Includes the rationale and references to the literature supporting the choice of each subgroup for inclusion in a genome-wide association study on breast cancer-specific survival. Supplementary Table S3. Shows the characteristics of the breast cancer patients included in the 15-year breast cancer-specific survival analyses, overall and by subgroup. Supplementary Table S4. Shows the characteristics of the breast cancer patients included in the 5-year breast cancer-specific survival analyses for subgroups defined based on type of systemic treatment received.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

La source scientifique ouverte est momentanément indisponible.

Les institutions déclarées

The Netherlands Cancer Institute QIMR Berghofer Medical Research Institute University of Toronto Lunenfeld-Tanenbaum Research Institute University of California, Irvine German Cancer Research Center Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa Fred Hutch Cancer Center University of Wisconsin–Milwaukee Lund University Universität Hamburg University Medical Center Hamburg-Eppendorf Universitätsklinikum Erlangen University of Cambridge Ruhr University Bochum Huntsman Cancer Institute Kaiser Permanente University of Pisa University Cancer Center Hamburg Roswell Park Comprehensive Cancer Center The University of Sydney WinnMed University of Sheffield Karolinska Institutet Fox Chase Cancer Center Medizinische Hochschule Hannover Centre international de recherche sur le cancer University of Westminster University of Southampton Harvard University Press University of Manchester University of California, Los Angeles Copenhagen University Hospital Curtin University Hospital Clínico San Carlos The University of Melbourne Cancer Council Victoria Australian Regenerative Medicine Institute Monash University University of Oulu Inserm Heidelberg University Helmholtz Munich University of Cologne University of Southern California California Southern University Stockholm South General Hospital University of Eastern Finland Finland University Erasmus MC Cancer Institute Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology University of Tübingen University of Oxford Pomeranian Medical University University Hospital Ulm Stanford University KU Leuven Oslo University Hospital University of Oslo City Of Hope National Medical Center University of Hawaiʻi at Mānoa Karolinska University Hospital Kuopio University Hospital University of California San Diego University Hospital of Heraklion Cyprus Institute of Neurology and Genetics University Health Network Health Net University of Helsinki University of North Carolina at Chapel Hill Queen's University Belfast American Cancer Society Fondazione IRCCS Istituto Nazionale dei Tumori IFOM Carmel Medical Center Hospital Universitario Puerta de Hierro Majadahonda University College London Hospitals NHS Foundation Trust University College London University Hospital of Larissa King's College London National Center for Tumor Diseases Ss. Cyril and Methodius University in Skopje The University of Western Australia Cornell University Columbia University Leiden University Medical Center University of Birmingham NordLab Uppsala University

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

BRCA gene mutations in cancerMultiple and Secondary Primary Cancers

Lire en accès ouvert Consulter la publication primaire Ouvrir le DOI